47 These symptoms are due to the drugs mechanisms of action, particularly delayed gastric emptying, and are the primary reason for treatment discontinuation, representing a major barrier to adherence
Conversely, a single-institution study of 1,191 participants failed to find a difference in the rate of new retinopathy or existing retinopathy progression between GLP-1/GIP agonist or SGLT2 inhibitors when the amount of hemoglobin A1c reduction was the same in the two treatment arms
GLP-1 receptors are not exclusively found in the pancreas
The most popular example of these advancements is Ozempic, a GLP-based drug that surpassed its predecessors
When considering this alongside GLP-1 therapy, your healthcare provider will review your health profile, medical history, and treatment goals to create a plan that works for you
Find articles by Wheeler, M